To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene USP13TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
209 supporting clones for gene USP13 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_003940.2   .a 1 to 7933 1 to 7933 exact RefSeq,   7933/7933
(100 %)
0 diff
(100 %id)
BM152928 leukopheresis .a 1 to 436 1 to 436   tiling clone,   436/438
(99 %)
9 diff
(98.0 %id)
U75362   .a 9 to 2725 22 to 2738 V96A     2717/2738
(99 %)
7 diff
(99.8 %id)
BX375254 Neuroblastoma Cot 25-normalized .a 12 to 427 1 to 419       419/419
(100 %)
12 diff
(97.2 %id)
BC016146 Uterus, leiomyosarcoma .a 48 to 2725 1 to 2678 exact tiling clone, available from MGC, AAA   2678/2678
(100 %)
0 diff
(100 %id)
AK290338 tongue, tumor tissue .a 54 to 2725 1 to 2672 I293V L305F T325A L338P     2672/2672
(100 %)
5 diff
(99.9 %id)
TI_1540413300   .a 54 to 375 345 to 25       322/376
(85 %)
0 diff
(100 %id)
DA452240 tongue, tumor tissue .a 55 to 637 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BE887384 leiomyosarcoma, uterus .a 68 to 701 1 to 635       635/1092
(58 %)
12 diff
(99.0 %id)
BQ877083 epidermoid carcinoma, cell line, lung .a 307 to 1158 1 to 861       861/896
(96 %)
19 diff
(97.9 %id)
DA063162 cerebellum .a 363 to 930 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BX350597   .a 375 to 1028 654 to 1       654/654
(100 %)
4 diff
(99.4 %id)
DB049741 testis .a 431 to 983 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BM449976 melanotic melanoma, skin .a 551 to 1456 4 to 916       913/1060
(86 %)
18 diff
(98.4 %id)
BE536088 cervix .a 565 to 1235 1 to 682       680/825
(82 %)
28 diff
(96.7 %id)
DA999263 breast, tumor tissue .a 612 to 1145 2 to 535   capped   534/535
(99 %)
1 diff
(99.9 %id)
BX501290 Liver .a 625 to 1364 1 to 740       740/740
(100 %)
2 diff
(99.8 %id)
DB193413 ovary, tumor tissue .a 636 to 1126 2 to 493   capped   492/492
(100 %)
1 diff
(99.8 %id)
AU124629   .a 646 to 1447 2 to 801   capped   800/800
(100 %)
8 diff
(99.0 %id)
AB040379 testis_normal .a 700 to 1084 382 to 1       382/388
(98 %)
6 diff
(98.5 %id)
AA160073 Pancreas .a 719 to 1021 1 to 308       308/344
(89 %)
7 diff
(98.0 %id)
AA248596   .a 733 to 974 1 to 245       245/250
(98 %)
11 diff
(95.6 %id)
DW419090 Liver .a 741 to 1133 17 to 409       393/409
(96 %)
8 diff
(98.1 %id)
BP204835 coronary artery .a 899 to 1483 1 to 585       585/585
(100 %)
11 diff
(98.2 %id)
BU151336 brain, neuroblastoma, cell line .a 916 to 1739 1 to 840       840/899
(93 %)
31 diff
(96.6 %id)
DB027560 testis .a 962 to 1559 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
BF376540 testis_normal .a 982 to 1359 59 to 437       379/440
(86 %)
12 diff
(97.3 %id)
AA181630   .a 1167 to 1374 1 to 211       211/212
(99 %)
6 diff
(97.2 %id)
AA182435   .a 1167 to 1615 1 to 454       452/515
(87 %)
20 diff
(96.2 %id)
AA211456   .a 1167 to 1667 1 to 506       508/517
(98 %)
13 diff
(97.5 %id)
AA211448   .a 1167 to 1508 1 to 348       348/352
(98 %)
7 diff
(98.1 %id)
DA605487   .a 1248 to 1790 2 to 545   capped   544/546
(99 %)
2 diff
(99.7 %id)
CA950442 Pancreas, Purified pancreatic islet .a 1256 to 1671 1 to 416       416/416
(100 %)
6 diff
(98.6 %id)
BM910803 astrocytoma grade IV, cell line, brain .a 1292 to 2002 1 to 717       717/1108
(64 %)
14 diff
(98.8 %id)
CK903129 Pancreas, Purified pancreatic islet .a 1293 to 1855 1 to 563     Submitted on the opposite strand 563/563
(100 %)
0 diff
(100 %id)
AA311884   .a 1301 to 1779 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
AW958624   .a 1302 to 1863 1 to 561       561/561
(100 %)
4 diff
(99.3 %id)
BF695122 muscle (skeletal) .a 1335 to 1887 1 to 556       556/838
(66 %)
27 diff
(96.8 %id)
BE837639 prostate_normal .a 1354 to 1881 537 to 13       525/537
(97 %)
0 diff
(100 %id)
DR422494 eye, Pterygium .a 1400 to 2066 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
BG531893 embryonal carcinoma, testis .a 1430 to 2029 1 to 594       594/902
(65 %)
14 diff
(98.5 %id)
BE544376 cervical carcinoma cell line, cervix .a 1519 to 2209 20 to 704       687/704
(97 %)
21 diff
(97.1 %id)
BG926935 cartilage .a 1567 to 2090 88 to 610       523/539
(97 %)
7 diff
(98.8 %id)
T85658 liver and spleen .a 1654 to 2004 1 to 357       357/489
(73 %)
8 diff
(98.4 %id)
BX102558 liver and spleen .a 1659 to 2386 1 to 728       728/728
(100 %)
0 diff
(100 %id)
CR742488 liver and spleen .a 1659 to 2386 1 to 728       728/728
(100 %)
0 diff
(100 %id)
CN424059 embryonic stem cells, cell lines H1, H7, andH9 .a 1690 to 2372 1 to 682       682/682
(100 %)
3 diff
(99.6 %id)
BQ306470 breast .a 1791 to 2366 579 to 6       574/601
(95 %)
10 diff
(98.4 %id)
BQ222207 epithelioid carcinoma, Pancreas .a 1872 to 2735 1 to 866       866/866
(100 %)
7 diff
(99.2 %id)
BG505224 embryonal carcinoma, testis .a 1880 to 2688 1 to 805       805/808
(99 %)
17 diff
(97.9 %id)
BP203753 coronary artery .a 1894 to 2458 1 to 567       567/575
(98 %)
8 diff
(98.7 %id)
DB084309 testis .a 1957 to 2523 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BE550614 pooled germ cell tumors .a 2030 to 2725 709 to 14   AAA   696/697
(99 %)
10 diff
(98.6 %id)
TI_149292507   .a 2033 to 2725 782 to 91   AAA   692/692
(100 %)
1 diff
(99.9 %id)
BM974597 lung .a 2089 to 2725 655 to 19   AAA   637/637
(100 %)
0 diff
(100 %id)
AJ710170 heart .a 2123 to 2598 1 to 475       475/475
(100 %)
4 diff
(99.2 %id)
CA950213 Pancreas, Purified pancreatic islet .a 2124 to 2724 603 to 1       603/603
(100 %)
14 diff
(97.7 %id)
BE562696 endometrium, adenocarcinoma cell line, uterus .a 2128 to 2739 1 to 606       606/772
(78 %)
9 diff
(98.9 %id)
BF092456 testis_normal .a 2136 to 2475 367 to 33       335/367
(91 %)
1 diff
(99.8 %id)
BF092477 testis_normal .a 2136 to 2474 361 to 28       334/361
(92 %)
1 diff
(99.8 %id)
BF830752 head_neck .a 2171 to 2604 438 to 4     Submitted on the opposite strand 435/441
(98 %)
12 diff
(97.3 %id)
AA165682 Pancreas .a 2171 to 2725 560 to 13   AAA   548/584
(93 %)
10 diff
(98.3 %id)
AU148456   .a 2171 to 2725 553 to 1       553/587
(94 %)
4 diff
(99.4 %id)
BQ354174 head_neck .a 2180 to 2494 1 to 317       317/327
(96 %)
13 diff
(96.1 %id)
AA190910   .a 2183 to 2726 546 to 1       546/547
(99 %)
8 diff
(98.6 %id)
AA190583   .a 2183 to 2725 542 to 1       542/544
(99 %)
1 diff
(99.9 %id)
AI700008 pooled germ cell tumors .a 2213 to 2725 514 to 1       514/515
(99 %)
9 diff
(98.3 %id)
AI284874 ovary, tumor, 5 pooled (see description) .a 2230 to 2728 498 to 1       498/498
(100 %)
5 diff
(99.0 %id)
AA181648   .a 2285 to 2724 442 to 1       442/447
(98 %)
4 diff
(99.2 %id)
BQ354173 head_neck .a 2301 to 2492 1 to 197       197/197
(100 %)
13 diff
(93.5 %id)
AV704196 adrenal gland .a 2307 to 2748 1 to 442       442/472
(93 %)
6 diff
(98.8 %id)
AV706372 adrenal gland .a 2307 to 2730 1 to 422       422/422
(100 %)
3 diff
(99.3 %id)
BF431345 Kidney .a 2310 to 2725 429 to 14   AAA   416/427
(97 %)
9 diff
(97.9 %id)
AW731757   .a 2340 to 2728 388 to 1       388/480
(80 %)
16 diff
(96.7 %id)
BM150964 leukopheresis .a 2359 to 2725 399 to 33   AAA   367/367
(100 %)
10 diff
(97.3 %id)
DC376785 brain .a 2405 to 2966 1 to 562       562/562
(100 %)
4 diff
(99.3 %id)
BE892755 melanotic melanoma, skin .a 2417 to 2725 1 to 309   AAA   309/309
(100 %)
0 diff
(100 %id)
AA181405   .a 2452 to 2720 270 to 1       270/270
(100 %)
1 diff
(99.7 %id)
AA181659   .a 2462 to 2725 265 to 1       265/265
(100 %)
1 diff
(99.7 %id)
BU683248 lung .a 2574 to 3261 703 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 685/685
(100 %)
3 diff
(99.6 %id)
BG576110 breast, mammary adenocarcinoma, cell line .a 2578 to 3187 35 to 656       622/809
(76 %)
6 diff
(99.3 %id)
BE904694 epithelioid carcinoma, Pancreas .a 2636 to 3289 1 to 654       654/968
(67 %)
14 diff
(98.6 %id)
AI803479 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2820 to 3261 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
BE875685 large cell carcinoma, undifferentiated, lung .a 2828 to 3313 1 to 489       489/502
(97 %)
8 diff
(98.5 %id)
BM463042 melanotic melanoma, skin .a 2843 to 3795 1 to 960   tiling clone,   960/960
(100 %)
17 diff
(98.3 %id)
AW517593 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2887 to 3267 390 to 1       390/390
(100 %)
8 diff
(98.0 %id)
BF670945 muscle (skeletal) .a 2904 to 3552 1 to 639       639/811
(78 %)
17 diff
(98.0 %id)
DA825004 pericardium .a 2920 to 3476 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AI038231 senescent fibroblast .a 2924 to 3267 357 to 14   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 344/344
(100 %)
2 diff
(99.5 %id)
R70174 breast .a 3235 to 3475 1 to 245       245/249
(98 %)
12 diff
(95.2 %id)
CR591494 HeLa cells Cot 25-normalized .a 3283 to 4953 1 to 1671   tiling clone,   1671/1671
(100 %)
0 diff
(100 %id)
BX384654   .a 3283 to 4094 1 to 811   fully sequenced,   811/811
(100 %)
1 diff
(99.9 %id)
AW069158 bone marrow stroma .a 3307 to 3901 613 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 595/595
(100 %)
1 diff
(99.9 %id)
AU253852 neuroblastoma .a 3394 to 4068 1 to 675       675/675
(100 %)
12 diff
(98.3 %id)
AK091484 brain .a 3398 to 6493 1 to 3094   tiling clone, available from FLJ,   3094/3094
(100 %)
6 diff
(99.9 %id)
DA500734 brain .a 3399 to 3948 2 to 553   capped   552/552
(100 %)
4 diff
(99.3 %id)
AL596734 human spinal cord .a 3526 to 3985 1 to 460       460/460
(100 %)
0 diff
(100 %id)
CX783191 human embryonic stem cells .a 3618 to 4439 1 to 822       822/822
(100 %)
0 diff
(100 %id)
AW175996 breast .a 3737 to 4335 10 to 609       600/728
(82 %)
6 diff
(99.2 %id)
BQ309487 breast .a 3753 to 4136 1 to 386       386/386
(100 %)
26 diff
(93.3 %id)
AW175991 breast .a 3755 to 4333 1 to 581       581/774
(75 %)
25 diff
(96.8 %id)
BE895657 melanotic melanoma, skin .a 3787 to 4457 1 to 671       671/980
(68 %)
17 diff
(98.3 %id)
AW581735 pnet .a 3788 to 4448 1 to 660       660/662
(99 %)
9 diff
(98.7 %id)
BM803817 leiomyosarcoma, uterus .a 3805 to 4678 1 to 887       887/1041
(85 %)
30 diff
(97.2 %id)
BX499855 Liver .a 3996 to 4577 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BC049199 Eye, retinoblastoma .a 4036 to 7931 1 to 3897   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 3897/3897
(100 %)
4 diff
(99.9 %id)
BE781903 eye, retinoblastoma .a 4057 to 4762 1 to 714   available from MGC,   714/940
(75 %)
28 diff
(97.1 %id)
BX384653   .a 4064 to 4953 890 to 1   fully sequenced,   890/890
(100 %)
6 diff
(99.4 %id)
BU164934 eye, retinoblastoma .a 4073 to 4946 1 to 875       875/876
(99 %)
9 diff
(99.0 %id)
AI905219 breast .a 4075 to 4331 304 to 45       260/312
(83 %)
0 diff
(100 %id)
BQ009180 Chondrosarcoma, Left Pubic Bone .a 4146 to 4925 797 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 779/779
(100 %)
1 diff
(99.9 %id)
CA427201 Bone, Subchondral Bone .a 4146 to 4925 792 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 774/774
(100 %)
6 diff
(99.3 %id)
BU856764 adenocarcinoma, cell line, breast .a 4178 to 4926 1 to 752   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 752/752
(100 %)
8 diff
(99.0 %id)
BC062766 skeletal muscle .a 4196 to 5460 1 to 1265   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 1265/1266
(99 %)
2 diff
(99.9 %id)
BF671885 muscle (skeletal) .a 4199 to 4924 1 to 716   available from MGC,   716/739
(96 %)
27 diff
(96.4 %id)
BU629359 cell lines, Chondrosarcoma .a 4216 to 4925 726 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 708/708
(100 %)
2 diff
(99.8 %id)
BP430537   .a 4292 to 4535 1 to 250       250/255
(98 %)
7 diff
(97.3 %id)
DA864713 placenta .a 4333 to 4820 2 to 486   capped   485/485
(100 %)
1 diff
(99.8 %id)
AI872417 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 4426 to 4925 500 to 1       500/500
(100 %)
0 diff
(100 %id)
AW295324   .a 4430 to 4933 520 to 17       504/520
(96 %)
0 diff
(100 %id)
AA932764 pooled germ cell tumors .a 4446 to 4933 488 to 1       488/488
(100 %)
0 diff
(100 %id)
AW304039 pooled .a 4475 to 4933 467 to 9       459/467
(98 %)
0 diff
(100 %id)
AI400932 Prostate .a 4493 to 4924 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
R71391 breast .a 4549 to 4920 378 to 1       378/378
(100 %)
6 diff
(98.5 %id)
AA993458   .a 4581 to 4933 356 to 4       353/356
(99 %)
0 diff
(100 %id)
BQ641436 eye, normal pigmented retinal epithelium .a 4598 to 5521 1 to 938       938/938
(100 %)
43 diff
(95.5 %id)
AI203935   .a 4610 to 4933 325 to 3       323/325
(99 %)
0 diff
(100 %id)
BX499622 Liver .a 4617 to 5350 1 to 733       733/733
(100 %)
7 diff
(99.1 %id)
AA383819 testis .a 4623 to 4969 1 to 350       350/350
(100 %)
5 diff
(98.6 %id)
BG992428 head_neck .a 4626 to 5062 450 to 14       437/450
(97 %)
0 diff
(100 %id)
CB164791 Liver .a 4851 to 5390 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BG575168 breast, mammary adenocarcinoma, cell line .a 5038 to 5849 1 to 812       812/812
(100 %)
14 diff
(98.3 %id)
BU858686 mixed (pool of 40 RNAs) .a 5606 to 6324 1 to 725       725/808
(89 %)
20 diff
(97.6 %id)
F00087 leg muscle, skeletal muscle .a 5690 to 5881 1 to 193       193/242
(79 %)
7 diff
(97.2 %id)
DA826276 pericardium .a 5762 to 6330 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA250241 caudate nucleus .a 5891 to 6451 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
CN273221 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5914 to 6299 1 to 386       386/386
(100 %)
0 diff
(100 %id)
DB315848 brain .a 5946 to 6493 550 to 1       550/550
(100 %)
2 diff
(99.7 %id)
DB306316 caudate nucleus .a 7382 to 7931 550 to 1       550/550
(100 %)
0 diff
(100 %id)
AK302404 testis .b 1 to 2747 1 to 2747 exact tiling clone,   2747/2747
(100 %)
0 diff
(100 %id)
DC400004 testis .b 1 to 505 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BQ883535 brain, neuroblastoma, cell line .c 1 to 599 1 to 612   tiling clone,   612/1011
(60 %)
29 diff
(97.2 %id)
AL042992 testis .c 86 to 847 49 to 799       751/808
(92 %)
20 diff
(97.6 %id)
DN997194 breast cancer, Mammary gland (cancer tissue) .c 326 to 1034 8 to 715       708/715
(99 %)
10 diff
(98.7 %id)
CR623689 B cells (Ramos cell line) Cot 25-normalized .c 381 to 2346 1 to 1966 exact tiling clone,   1966/1966
(100 %)
0 diff
(100 %id)
BX384965   .c 381 to 1359 1 to 975       975/975
(100 %)
8 diff
(99.2 %id)
BX384964   .c 1365 to 2346 978 to 1       978/982
(99 %)
7 diff
(99.3 %id)
BQ880738 dorsal root ganglia .d 1 to 897 1 to 902 L265V Q266T P267A G268R E269X ... tiling clone,   902/906
(99 %)
6 diff
(99.4 %id)
BQ775545 Bone, Human Chondrosarcoma Cell Line .e 1 to 694 710 to 19 M31W G32A A33P E34R V35C ... tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 692/692
(100 %)
2 diff
(99.8 %id)
BG107655 Bone, osteosarcoma, cell line .f-u -10 to 296 307 to 1     Submitted on the opposite strand 307/1784
(17 %)
3 diff
(99.9 %id)
DA823803 pericardium .f-u 1 to 534 2 to 535 exact tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
CN266929 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f-u 279 to 1043 1 to 767       767/767
(100 %)
3 diff
(99.7 %id)
BM803881 leiomyosarcoma, uterus .f-u 353 to 563 231 to 22     Submitted on the opposite strand 210/233
(90 %)
0 diff
(100 %id)
CF264969 Brain glioblastoma .f-u 438 to 1300 1 to 863   tiling clone,   863/863
(100 %)
3 diff
(99.7 %id)
BF247187 hypernephroma, Kidney .f-u 513 to 1065 1 to 552       552/775
(71 %)
18 diff
(97.7 %id)
H98058 melanocyte .f-u 525 to 989 1 to 471       471/504
(93 %)
12 diff
(97.7 %id)
BF350233 head_neck .f-u 602 to 728 13 to 138       126/143
(88 %)
2 diff
(98.7 %id)
BF350245 head_neck .f-u 602 to 711 111 to 1       111/115
(96 %)
0 diff
(100 %id)
BG283616 adenocarcinoma, cell line, Prostate .f-u 791 to 1446 1 to 653       653/653
(100 %)
10 diff
(98.5 %id)
AI457613 pooled .f-u 813 to 1247 437 to 3       435/437
(99 %)
0 diff
(100 %id)
BQ436898 melanotic melanoma, skin .f-u 865 to 1260 1 to 401       401/758
(52 %)
7 diff
(99.1 %id)
N35872 melanocyte .f-u 925 to 1129 1 to 205       205/207
(99 %)
1 diff
(99.6 %id)
BX119002 liver and spleen .f-u 1020 to 1500 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
R07668 liver and spleen .f-u 1021 to 1190 1 to 170       170/170
(100 %)
0 diff
(100 %id)
BF670689 muscle (skeletal) .f-u 1025 to 1686 1 to 651   tiling clone,   651/862
(75 %)
20 diff
(97.7 %id)
BM824934 Ascites, stomach .f-u 1056 to 1575 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
TI_149287558   .f-u 1208 to 1983 851 to 76   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 776/1082
(71 %)
13 diff
(98.8 %id)
BM972859 lung .f-u 1276 to 1983 725 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 709/709
(100 %)
2 diff
(99.8 %id)
BQ014945 Chondrosarcoma, Left Pubic Bone .f-u 1288 to 1983 712 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 696/696
(100 %)
0 diff
(100 %id)
BF109140 pooled .f-u 1305 to 1982 679 to 1       679/682
(99 %)
13 diff
(98.1 %id)
BU619563 Cell Line, Chondrosarcoma .f-u 1319 to 1983 681 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 665/665
(100 %)
1 diff
(99.9 %id)
AA193472.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1348 to 1971 1 to 621     also hits gene PLXDC2 621/626
(99 %)
14 diff
(97.8 %id)
BQ447612 Knee, Osteoarthritic Cartilage .f-u 1352 to 1983 647 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 631/639
(98 %)
5 diff
(99.3 %id)
AW022971 cochlea, ear .f-u 1388 to 1920 28 to 560       533/560
(95 %)
6 diff
(99.0 %id)
TI_149293218   .f-u 1390 to 1983 675 to 84   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 592/964
(61 %)
6 diff
(99.4 %id)
BU682554 lung .f-u 1390 to 1983 610 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 592/592
(100 %)
6 diff
(99.0 %id)
AA193520 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1412 to 1985 577 to 4       574/577
(99 %)
0 diff
(100 %id)
AI279566 carcinoid, lung .f-u 1475 to 1983 509 to 1       509/509
(100 %)
0 diff
(100 %id)
AA385698 thyroid gland .f-u 1491 to 1651 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
AW959106   .f-u 1500 to 1982 483 to 1     Submitted on the opposite strand 483/483
(100 %)
6 diff
(98.8 %id)
AA644364 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1503 to 1983 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AA904026 carcinoid, lung .f-u 1522 to 1982 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI380634 B-cell, chronic lymphotic leukemia .f-u 1523 to 1985 466 to 4       463/466
(99 %)
0 diff
(100 %id)
AI936251 normal prostate, Prostate .f-u 1532 to 1983 452 to 1       452/454
(99 %)
6 diff
(98.7 %id)
AI804164 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1535 to 1983 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AI633726 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1556 to 1984 429 to 1       429/429
(100 %)
0 diff
(100 %id)
AI193905 lung .f-u 1561 to 1983 435 to 13   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 423/423
(100 %)
0 diff
(100 %id)
F36831 pectoral muscle (after mastectomy) .f-u 1561 to 1919 1 to 359       359/360
(99 %)
1 diff
(99.8 %id)
AI125572   .f-u 1570 to 1983 435 to 22   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
AI375881 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1580 to 1985 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
F20217 pectoral muscle (after mastectomy) .f-u 1580 to 1974 1 to 396       396/396
(100 %)
1 diff
(99.8 %id)
AA402137   .f-u 1585 to 1971 1 to 386       386/386
(100 %)
1 diff
(99.8 %id)
F29207 pectoral muscle (after mastectomy) .f-u 1590 to 1933 1 to 344       344/344
(100 %)
0 diff
(100 %id)
AA701289 liver and spleen .f-u 1593 to 1983 391 to 1       391/391
(100 %)
0 diff
(100 %id)
F27411 pectoral muscle (after mastectomy) .f-u 1602 to 1983 1 to 382   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 382/382
(100 %)
1 diff
(99.8 %id)
BQ448434 Knee, Osteoarthritic Cartilage .f-u 1607 to 1983 393 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 377/377
(100 %)
0 diff
(100 %id)
BE646331 Prostate .f-u 1609 to 1985 388 to 12       377/388
(97 %)
0 diff
(100 %id)
BG282877 adenocarcinoma, cell line, Prostate .f-u 1617 to 1983 1 to 368   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 368/368
(100 %)
1 diff
(99.8 %id)
AA506150 colon .f-u 1643 to 1983 362 to 22   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 341/341
(100 %)
0 diff
(100 %id)
BG149907 carcinoid, lung .f-u 1650 to 1985 341 to 6       336/355
(94 %)
0 diff
(100 %id)
H97419 melanocyte .f-u 1659 to 1983 327 to 1       327/327
(100 %)
2 diff
(99.4 %id)
R07624 liver and spleen .f-u 1660 to 1977 320 to 3       318/320
(99 %)
0 diff
(100 %id)
AA594875 normal prostate, Prostate .f-u 1661 to 1822 163 to 1       163/163
(100 %)
3 diff
(98.2 %id)
BE765154 nervous_tumor .f-u 1671 to 1900 1 to 230       230/230
(100 %)
2 diff
(99.2 %id)
AJ573788 pectoral muscle (after mastectomy) .f-u 1681 to 1985 1 to 304       304/305
(99 %)
2 diff
(99.4 %id)
AI819283 2 pooled tumors (clear cell type), Kidney .f-u 1712 to 1983 285 to 14   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 272/272
(100 %)
0 diff
(100 %id)
AA629108   .f-u 1750 to 1983 234 to 1       234/234
(100 %)
0 diff
(100 %id)
AI673782 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1765 to 1958 194 to 1       194/201
(96 %)
1 diff
(99.6 %id)
AI570488 anaplastic oligodendroglioma, brain .f-u 1799 to 1985 204 to 18       187/204
(91 %)
0 diff
(100 %id)
AJ711472 heart .f-u 1818 to 1986 203 to 35     Submitted on the opposite strand 169/203
(83 %)
0 diff
(100 %id)
CD299985 testis .g-u 1 to 346 8 to 353 exact tiling clone,   346/354
(97 %)
3 diff
(99.2 %id)
BX499843 Liver .g-u 346 to 928 1 to 584   tiling clone,   584/584
(100 %)
2 diff
(99.7 %id)
TI_149294494   .g-u 386 to 1197 877 to 79   tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 799/803
(99 %)
15 diff
(98.2 %id)
AA780506   .h-u 1 to 568 566 to 1   tiling clone,   566/566
(100 %)
12 diff
(97.9 %id)
BX508160   .h-u 420 to 1049 1 to 631 T10N S88F I89Y T90H tiling clone,   631/631
(100 %)
7 diff
(98.9 %id)
BX508155   .h-u 441 to 1035 1 to 596   tiling clone,   596/596
(100 %)
5 diff
(99.2 %id)
BF882695 lung_tumor .i 1 to 509 1 to 509 exact tiling clone,   509/509
(100 %)
1 diff
(99.9 %id)
DW440951 Liver .j-u 1 to 365 18 to 382 W22R tiling clone,   365/382
(95 %)
6 diff
(98.5 %id)
AV714759   Gene USP13, variant not shown         Suspected internal deletion, this clone was ignored    
BM455427 lymph, lymphoma, cell line Gene USP13, variant not shown         This clone was ignored    
BQ062416 lymph, lymphoma, cell line Gene USP13, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h-u, .i, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI